Comments
Loading...
Mustang Bio (MBIO) Forecast
NewsEarningsMustang Bio (MBIO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMustang Bio (NASDAQ:MBIO) Stock Quotes, Forecast and News Summary
Mustang Bio Stock (NASDAQ: MBIO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Mustang Bio (MBIO) stock?
You can purchase shares of Mustang Bio (NASDAQ:MBIO) through any online brokerage.
Who are Mustang Bio (MBIO) competitors?
Other companies in Mustang Bio’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Vincerx Pharma (NASDAQ:VINC), Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR) and Synaptogenix (NASDAQ:SNPX).
What is the forecast, or price target, for Mustang Bio (MBIO) stock?
Mustang Bio has a consensus price target of $12.00.
What is the current price for Mustang Bio (MBIO)?
The stock price for Mustang Bio (NASDAQ: MBIO) is $4.37 last updated January 24, 2025 at 9:00 AM EST.
Does Mustang Bio (MBIO) pay a dividend?
There are no upcoming dividends for Mustang Bio.
When is Mustang Bio (NASDAQ:MBIO) reporting earnings?
Mustang Bio’s Q4 earnings are confirmed for Monday, March 10, 2025.
Is Mustang Bio (MBIO) going to split?
There is no upcoming split for Mustang Bio.
What sector and industry does Mustang Bio (MBIO) operate in?
Mustang Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.